As of 2025-05-14, the Intrinsic Value of Syngene International Ltd (SYNGENE.NS) is 178.68 INR. This SYNGENE.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 629.45 INR, the upside of Syngene International Ltd is -71.60%.
The range of the Intrinsic Value is 144.72 - 236.35 INR
Based on its market price of 629.45 INR and our intrinsic valuation, Syngene International Ltd (SYNGENE.NS) is overvalued by 71.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 144.72 - 236.35 | 178.68 | -71.6% |
| DCF (Growth 10y) | 174.10 - 273.42 | 211.36 | -66.4% |
| DCF (EBITDA 5y) | 246.16 - 416.66 | 325.52 | -48.3% |
| DCF (EBITDA 10y) | 245.06 - 415.84 | 321.00 | -49.0% |
| Fair Value | 61.75 - 61.75 | 61.75 | -90.19% |
| P/E | 199.10 - 493.36 | 301.90 | -52.0% |
| EV/EBITDA | 215.76 - 434.33 | 330.05 | -47.6% |
| EPV | 137.25 - 171.54 | 154.40 | -75.5% |
| DDM - Stable | 72.49 - 157.33 | 114.91 | -81.7% |
| DDM - Multi | 111.87 - 190.52 | 141.14 | -77.6% |
| Market Cap (mil) | 252,894.12 |
| Beta | 0.68 |
| Outstanding shares (mil) | 401.77 |
| Enterprise Value (mil) | 255,002.12 |
| Market risk premium | 8.31% |
| Cost of Equity | 13.50% |
| Cost of Debt | 5.73% |
| WACC | 13.30% |